Pages that link to "Q24810666"
Jump to navigation
Jump to search
The following pages link to Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region (Q24810666):
Displaying 15 items.
- Regulation of immunity and oncogenesis by the IRF transcription factor family (Q24293755) (← links)
- Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias. (Q34106877) (← links)
- Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. (Q34282231) (← links)
- Promoter methylation and expression levels of selected hematopoietic genes in pediatric B-cell acute lymphoblastic leukemia. (Q35226606) (← links)
- IRF-4 suppresses BCR/ABL transformation of myeloid cells in a DNA binding-independent manner (Q35693948) (← links)
- IRF-4 functions as a tumor suppressor in early B-cell development (Q36948612) (← links)
- Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity (Q38161582) (← links)
- Determining the global DNA methylation status of rat according to the identifier repetitive elements (Q38394221) (← links)
- Constitutive activation of SHP2 in mice cooperates with ICSBP deficiency to accelerate progression to acute myeloid leukemia (Q41814200) (← links)
- Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells (Q41825668) (← links)
- The IRF family of transcription factors: Inception, impact and implications in oncogenesis (Q41888239) (← links)
- Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway (Q47790213) (← links)
- Decitibine improve the efficiency of anti-PD-1 therapy via activating the response to IFN/PD-L1 signal of lung cancer cells (Q50107002) (← links)
- Quantification of CpG methylation at the 5'-region of XIST by pyrosequencing from human serum. (Q53567996) (← links)
- B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion (Q90181909) (← links)